quant Healthcare Fund - Direct - Growth
Equity Scheme by quant Money Managers Limited
3Y Returns (CAGR)
20.81%
Expense Ratio
1.51%
as of 01/07/2026
AUM
₹132.61 Cr
Qtr End: Mar 26
NAV
₹18.133
as of 17/07/2026
3Y Returns (CAGR)
20.81%
Expense Ratio
1.51%
as of 01/07/2026
AUM
₹132.61 Cr
Qtr End: Mar 26
NAV
₹18.133
as of 17/07/2026
Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
| Period | Returns | CAGR | Volatility |
|---|---|---|---|
| 3M | 13.74% | 67.34% | 14.77% |
| 6M | 20.95% | 46.28% | 18.03% |
| 1Y | 12.50% | 12.50% | 16.00% |
| 3Y | 76.33% | 20.81% | 17.29% |
| 5Y | N/A | N/A | N/A |
Scheme Details
- Launch Date
- 27/06/2023
- Fund Age
- 3.1 years
- Minimum Investment
- ₹5,000
- Fund House
- quant Mutual Fund
- Category
- Equity Scheme
- Sub-category
- Sectoral/ Thematic (Equity Scheme)
Similar Funds
Top funds in the same category and sub-category.
Nippon India Taiwan Equity Fund - Direct - Growth
3Y CAGR53.71%
TER0.85%
AUM₹106.62 Cr
Franklin Asian Equity Fund - Direct - Growth
3Y CAGR19.67%
TER1.66%
AUM₹181.05 Cr
Nippon India Japan Equity Fund - Direct - Growth
3Y CAGR20.68%
TER1.29%
AUM₹226.37 Cr
quant BFSI Fund - Direct - Growth
3Y CAGR26.82%
TER1.88%
AUM₹208.06 Cr
HDFC Transportation and Logistics Fund - Direct - Growth
3Y CAGR-
TER0.97%
AUM₹361.67 Cr
SBI Automotive Opportunities Fund - Direct - Growth
3Y CAGR-
TER0.99%
AUM₹711.62 Cr
ICICI Prudential US Bluechip Equity Fund - Direct - Growth
3Y CAGR13.85%
TER1.14%
AUM₹1,657.39 Cr